R T Carson
Overview
Explore the profile of R T Carson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stephenson J, Buono J, Spalding W, Cai Q, Tan H, Carson R, et al.
Value Health
. 2016 May;
17(7):A370.
PMID: 27200787
No abstract available.
2.
Williams V, Nelson L, Fehnel S, MacDougall J, Carson R, Tourkodimitris S, et al.
Aliment Pharmacol Ther
. 2014 Jun;
40(3):298-308.
PMID: 24943204
Background: Historically, measures of symptom severity of irritable bowel syndrome with constipation (IBS-C) in clinical trials have not met the evidence requirements described in the FDA guidance on patient-reported outcomes...
3.
Macdougall J, Johnston J, Lavins B, Nelson L, Williams V, Carson R, et al.
Neurogastroenterol Motil
. 2013 Feb;
25(6):481-6.
PMID: 23384406
Background: Our objective was to evaluate the performance of the Food and Drug Administration (FDA) Responder Endpoint for clinical trials in IBS-C, using data from two large Phase 3 clinical...
4.
Ganiats T, Carson R, Hamm R, Cantor S, Sumner W, Spann S, et al.
Med Decis Making
. 2000 Aug;
20(3):263-70.
PMID: 10929848
Context: Time preference (how preference for an outcome changes depending on when the outcome occurs) affects clinical decisions, but little is known about determinants of time preferences in clinical settings....
5.
Carson R, Vignali D
J Immunol Methods
. 1999 Sep;
227(1-2):41-52.
PMID: 10485253
Several methods have been developed to quantify cytokines and chemokines in biological fluids and tissue culture samples, including bioassays, enzyme-linked immunosorbent assay (ELISA), intracellular staining, ribonuclease protection assay (RPA) and...
6.
Carson R, Desai D, Vignali K, Vignali D
J Immunol
. 1999 Jan;
162(1):1-4.
PMID: 9886362
Th cells recognize protein Ags as short peptides bound to MHC class II molecules. Altered peptide ligands can antagonize (inhibit) T cell responses to stimulatory peptides. Peptides generated by APC...
7.
Carson R, Vignali K, Woodland D, Vignali D
Immunity
. 1997 Nov;
7(3):387-99.
PMID: 9324359
Naturally processed MHC class II-bound peptides possess ragged NH2 and COOH termini. It is not known whether these peptide flanking residues (PFRs), which lie outside the MHC anchor residues, are...
8.
Walker W, Castrucci M, Sangster M, Carson R, Kawaoka Y
J Immunol
. 1997 Sep;
159(6):2563-6.
PMID: 9300673
Reverse genetics was used to modify the influenza virus genome by inserting the p46-63 sequence of hen egg lysozyme (HEL) into the neuraminidase stalk of the virus. The resulting virus,...
9.
Thierfelder W, Van Deursen J, Yamamoto K, Tripp R, Sarawar S, Carson R, et al.
Nature
. 1996 Jul;
382(6587):171-4.
PMID: 8700208
Signal transducers and activators of transcription (STATs) are activated by tyrosine phosphorylation in response to cytokines and mediate many of their functional responses. Stat4 was initially cloned as a result...
10.
Vignali D, Carson R, Chang B, Mittler R, Strominger J
J Exp Med
. 1996 May;
183(5):2097-107.
PMID: 8642320
During T cell activation, CD4 is intimately involved in colocalizing the T cell receptor (TCR) with its specific peptide ligand bound to class II molecules of the major histocompatibility complex...